Global Talazoparib Market Growth 2025-2031

December 2025 | 83 pages | ID: G90548C469CEN
LP Information

Abstracts

The global Talazoparib market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

United States market for Talazoparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Talazoparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Talazoparib is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Talazoparib players cover Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Talazoparib Industry Forecast” looks at past sales and reviews total world Talazoparib sales in 2024, providing a comprehensive analysis by region and market sector of projected Talazoparib sales for 2025 through 2031. With Talazoparib sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Talazoparib industry.

This Insight Report provides a comprehensive analysis of the global Talazoparib landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Talazoparib portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Talazoparib market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Talazoparib and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Talazoparib.

This report presents a comprehensive overview, market shares, and growth opportunities of Talazoparib market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 0.25mg Capsules
• 1mg Capsules

Segmentation by Application:

• Hospital
• Drug Center
• Clinic
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Talazoparib market?

What factors are driving Talazoparib market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Talazoparib market opportunities vary by end market size?

How does Talazoparib break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Talazoparib Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Talazoparib by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Talazoparib by Country/Region, 2020, 2024 & 2031
2.2 Talazoparib Segment by Type
  2.2.1 0.25mg Capsules
  2.2.2 1mg Capsules
2.3 Talazoparib Sales by Type
  2.3.1 Global Talazoparib Sales Market Share by Type (2020-2025)
  2.3.2 Global Talazoparib Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Talazoparib Sale Price by Type (2020-2025)
2.4 Talazoparib Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Center
  2.4.3 Clinic
  2.4.4 Others
2.5 Talazoparib Sales by Application
  2.5.1 Global Talazoparib Sale Market Share by Application (2020-2025)
  2.5.2 Global Talazoparib Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Talazoparib Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Talazoparib Breakdown Data by Company
  3.1.1 Global Talazoparib Annual Sales by Company (2020-2025)
  3.1.2 Global Talazoparib Sales Market Share by Company (2020-2025)
3.2 Global Talazoparib Annual Revenue by Company (2020-2025)
  3.2.1 Global Talazoparib Revenue by Company (2020-2025)
  3.2.2 Global Talazoparib Revenue Market Share by Company (2020-2025)
3.3 Global Talazoparib Sale Price by Company
3.4 Key Manufacturers Talazoparib Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Talazoparib Product Location Distribution
  3.4.2 Players Talazoparib Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TALAZOPARIB BY GEOGRAPHIC REGION

4.1 World Historic Talazoparib Market Size by Geographic Region (2020-2025)
  4.1.1 Global Talazoparib Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Talazoparib Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Talazoparib Market Size by Country/Region (2020-2025)
  4.2.1 Global Talazoparib Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Talazoparib Annual Revenue by Country/Region (2020-2025)
4.3 Americas Talazoparib Sales Growth
4.4 APAC Talazoparib Sales Growth
4.5 Europe Talazoparib Sales Growth
4.6 Middle East & Africa Talazoparib Sales Growth

5 AMERICAS

5.1 Americas Talazoparib Sales by Country
  5.1.1 Americas Talazoparib Sales by Country (2020-2025)
  5.1.2 Americas Talazoparib Revenue by Country (2020-2025)
5.2 Americas Talazoparib Sales by Type (2020-2025)
5.3 Americas Talazoparib Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Talazoparib Sales by Region
  6.1.1 APAC Talazoparib Sales by Region (2020-2025)
  6.1.2 APAC Talazoparib Revenue by Region (2020-2025)
6.2 APAC Talazoparib Sales by Type (2020-2025)
6.3 APAC Talazoparib Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Talazoparib by Country
  7.1.1 Europe Talazoparib Sales by Country (2020-2025)
  7.1.2 Europe Talazoparib Revenue by Country (2020-2025)
7.2 Europe Talazoparib Sales by Type (2020-2025)
7.3 Europe Talazoparib Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Talazoparib by Country
  8.1.1 Middle East & Africa Talazoparib Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Talazoparib Revenue by Country (2020-2025)
8.2 Middle East & Africa Talazoparib Sales by Type (2020-2025)
8.3 Middle East & Africa Talazoparib Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Talazoparib
10.3 Manufacturing Process Analysis of Talazoparib
10.4 Industry Chain Structure of Talazoparib

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Talazoparib Distributors
11.3 Talazoparib Customer

12 WORLD FORECAST REVIEW FOR TALAZOPARIB BY GEOGRAPHIC REGION

12.1 Global Talazoparib Market Size Forecast by Region
  12.1.1 Global Talazoparib Forecast by Region (2026-2031)
  12.1.2 Global Talazoparib Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Talazoparib Forecast by Type (2026-2031)
12.7 Global Talazoparib Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Pfizer
  13.1.1 Pfizer Company Information
  13.1.2 Pfizer Talazoparib Product Portfolios and Specifications
  13.1.3 Pfizer Talazoparib Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Pfizer Main Business Overview
  13.1.5 Pfizer Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Talazoparib Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Talazoparib Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 0.25mg Capsules
Table 4. Major Players of 1mg Capsules
Table 5. Global Talazoparib Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Talazoparib Sales Market Share by Type (2020-2025)
Table 7. Global Talazoparib Revenue by Type (2020-2025) & ($ million)
Table 8. Global Talazoparib Revenue Market Share by Type (2020-2025)
Table 9. Global Talazoparib Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Talazoparib Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Talazoparib Sale Market Share by Application (2020-2025)
Table 12. Global Talazoparib Revenue by Application (2020-2025) & ($ million)
Table 13. Global Talazoparib Revenue Market Share by Application (2020-2025)
Table 14. Global Talazoparib Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Talazoparib Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Talazoparib Sales Market Share by Company (2020-2025)
Table 17. Global Talazoparib Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Talazoparib Revenue Market Share by Company (2020-2025)
Table 19. Global Talazoparib Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Talazoparib Producing Area Distribution and Sales Area
Table 21. Players Talazoparib Products Offered
Table 22. Talazoparib Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Talazoparib Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Talazoparib Sales Market Share Geographic Region (2020-2025)
Table 27. Global Talazoparib Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Talazoparib Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Talazoparib Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Talazoparib Sales Market Share by Country/Region (2020-2025)
Table 31. Global Talazoparib Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Talazoparib Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Talazoparib Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Talazoparib Sales Market Share by Country (2020-2025)
Table 35. Americas Talazoparib Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Talazoparib Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Talazoparib Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Talazoparib Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Talazoparib Sales Market Share by Region (2020-2025)
Table 40. APAC Talazoparib Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Talazoparib Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Talazoparib Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Talazoparib Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Talazoparib Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Talazoparib Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Talazoparib Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Talazoparib Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Talazoparib Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Talazoparib Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Talazoparib Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Talazoparib
Table 52. Key Market Challenges & Risks of Talazoparib
Table 53. Key Industry Trends of Talazoparib
Table 54. Talazoparib Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Talazoparib Distributors List
Table 57. Talazoparib Customer List
Table 58. Global Talazoparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Talazoparib Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Talazoparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Talazoparib Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Talazoparib Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Talazoparib Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Talazoparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Talazoparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Talazoparib Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Talazoparib Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Talazoparib Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Talazoparib Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Talazoparib Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Talazoparib Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Talazoparib Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Talazoparib Product Portfolios and Specifications
Table 74. Pfizer Talazoparib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Talazoparib
Figure 2. Talazoparib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Talazoparib Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Talazoparib Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Talazoparib Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Talazoparib Sales Market Share by Country/Region (2024)
Figure 10. Talazoparib Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 0.25mg Capsules
Figure 12. Product Picture of 1mg Capsules
Figure 13. Global Talazoparib Sales Market Share by Type in 2025
Figure 14. Global Talazoparib Revenue Market Share by Type (2020-2025)
Figure 15. Talazoparib Consumed in Hospital
Figure 16. Global Talazoparib Market: Hospital (2020-2025) & (K Pcs)
Figure 17. Talazoparib Consumed in Drug Center
Figure 18. Global Talazoparib Market: Drug Center (2020-2025) & (K Pcs)
Figure 19. Talazoparib Consumed in Clinic
Figure 20. Global Talazoparib Market: Clinic (2020-2025) & (K Pcs)
Figure 21. Talazoparib Consumed in Others
Figure 22. Global Talazoparib Market: Others (2020-2025) & (K Pcs)
Figure 23. Global Talazoparib Sale Market Share by Application (2024)
Figure 24. Global Talazoparib Revenue Market Share by Application in 2025
Figure 25. Talazoparib Sales by Company in 2025 (K Pcs)
Figure 26. Global Talazoparib Sales Market Share by Company in 2025
Figure 27. Talazoparib Revenue by Company in 2025 ($ millions)
Figure 28. Global Talazoparib Revenue Market Share by Company in 2025
Figure 29. Global Talazoparib Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Talazoparib Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Talazoparib Sales 2020-2025 (K Pcs)
Figure 32. Americas Talazoparib Revenue 2020-2025 ($ millions)
Figure 33. APAC Talazoparib Sales 2020-2025 (K Pcs)
Figure 34. APAC Talazoparib Revenue 2020-2025 ($ millions)
Figure 35. Europe Talazoparib Sales 2020-2025 (K Pcs)
Figure 36. Europe Talazoparib Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Talazoparib Sales 2020-2025 (K Pcs)
Figure 38. Middle East & Africa Talazoparib Revenue 2020-2025 ($ millions)
Figure 39. Americas Talazoparib Sales Market Share by Country in 2025
Figure 40. Americas Talazoparib Revenue Market Share by Country (2020-2025)
Figure 41. Americas Talazoparib Sales Market Share by Type (2020-2025)
Figure 42. Americas Talazoparib Sales Market Share by Application (2020-2025)
Figure 43. United States Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Talazoparib Sales Market Share by Region in 2025
Figure 48. APAC Talazoparib Revenue Market Share by Region (2020-2025)
Figure 49. APAC Talazoparib Sales Market Share by Type (2020-2025)
Figure 50. APAC Talazoparib Sales Market Share by Application (2020-2025)
Figure 51. China Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 55. India Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Talazoparib Sales Market Share by Country in 2025
Figure 59. Europe Talazoparib Revenue Market Share by Country (2020-2025)
Figure 60. Europe Talazoparib Sales Market Share by Type (2020-2025)
Figure 61. Europe Talazoparib Sales Market Share by Application (2020-2025)
Figure 62. Germany Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 63. France Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Talazoparib Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Talazoparib Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Talazoparib Sales Market Share by Application (2020-2025)
Figure 70. Egypt Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Talazoparib Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Talazoparib in 2025
Figure 76. Manufacturing Process Analysis of Talazoparib
Figure 77. Industry Chain Structure of Talazoparib
Figure 78. Channels of Distribution
Figure 79. Global Talazoparib Sales Market Forecast by Region (2026-2031)
Figure 80. Global Talazoparib Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Talazoparib Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Talazoparib Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Talazoparib Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Talazoparib Revenue Market Share Forecast by Application (2026-2031)